September 18, 2014 9:50 PM ET

Biotechnology

Company Overview of Biolex Therapeutics, Inc.

Company Overview

On August 25, 2014, Biolex Therapeutics, Inc. went out of business as per its Chapter 7 liquidation filing under bankruptcy. Biolex Therapeutics, Inc. operates as a biopharmaceutical company. It offers Locteron, a controlled-release interferon alfa for the treatment of hepatitis C; BLX-155, a thrombolytic or clot buster to dissolve blood clots; and BLX-301, an antibody for the treatment of B-cell lymphoma. Biolex Therapeutics, Inc. has a research and development collaboration with Merial Limited to produce veterinary vaccines. The company was formerly known as Biolex, Inc. and changed its name to Biolex Therapeutics, Inc. in November, 2007. The company was founded in 1997 and is based in Pit...

158 Credle Street

Pittsboro, NC 27312

United States

Founded in 1997

106 Employees

Phone:

919-542-9901

Fax:

919-542-9910

Key Executives for Biolex Therapeutics, Inc.

Biolex Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Receptor BioLogix, Inc. United States
Invogene Therapeutics United States
Clark Laboratories Inc. United States
Novatrix Biomedical, Inc. United States
Molecular Matrix, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biolex Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.